 Home > Medical News > Latest Medical News > Borui Biologics ``Infliximab'' biosimilar drug approved for marketing

Borui Biologics ``Infliximab'' biosimilar drug approved for marketing

 Last Update: 2021-11-05
 Source: Internet
 Author: User

Tags

anti ro antibody

1 3 cyclohexadiene

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Text|Pharmaceutical Mission Hills

On September 28, the National Food and Drug Administration (NMPA) announced that the infliximab for injection declared by Hisun Biologics, a wholly-owned subsidiary of Zhejiang Borui Biopharmaceutical Co.

Screenshot source: NMPA official website

Infliximab is an anti-tumor necrosis factor (TNF-a) monoclonal antibody, the original drug is Johnson & Johnson's similar

Borui Bio's infliximab for injection is a gram-like biosimilar.

According to a public press release issued by Borui Bio, its infliximab for injection was developed in strict accordance with the guidelines for biosimilar drugs, and pharmacy, non-clinical and clinical trials (pharmacokinetics, effectiveness, safety and immunogenicity) Equal comparison study) The results of the comparison study are all highly similar to the original drug

Reference materials:

[1] On September 28, 2021, the drug approval document pending information is released.

[3] Zhejiang Hisun Pharmaceutical Co.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.